Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic
- Conditions
- AnxietyDepressionCOVID-19Pregnancy ComplicationsPtsdMental Health Wellness 1Coronavirus
- Interventions
- Other: This is an online survey with no intervention.
- Registration Number
- NCT04385238
- Lead Sponsor
- Pregistry
- Brief Summary
The purpose of this study is to assess the health and wellbeing of pregnant and recently pregnant women during the COVID-19 pandemic using an online survey.
- Detailed Description
Millions of women will give birth during the pandemic of Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The consequences of COVID-19 for pregnant women and their offspring are unknown. This lack of information leads to anxiety among pregnant women, women who are considering getting pregnant, and their families. It is therefore important to assess the wellbeing and mental health of women during the COVID-19 pandemic.
The international nature of the online survey will allow the evaluation of how living during the COVID-19 pandemic affects pregnant and recently pregnant women at a global level, including the evaluation of potential cultural and geographic differences.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 6894
- Pregnant women or women who have been pregnant within the last 6 months
- Able to give electronic informed consent
- <18 years of age
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Pregnant Women This is an online survey with no intervention. Pregnant women who are 18 years of age or older. Post-partum women This is an online survey with no intervention. Women who gave birth within the last 6 months who are 18 years of age or older.
- Primary Outcome Measures
Name Time Method Number of Participants With Symptoms of Anxiety and Depression Anytime during pregnancy or within 6 months after given birth. Symptoms of anxiety and depression will be measured by the Patient Health Questionnaire-4 (PHQ-4) which combines two ultrabrief screeners: the PHQ-2 and the Generalised Anxiety Disorder Scale. Participants will be asked to report their symptoms of depression and anxiety in the past 2 weeks on a Likert Scale from 0 (not at all) to 3 (nearly every day) for a maximum score of 12.
Number of Participants With Symptoms of Post-traumatic Stress Disorder Anytime during pregnancy or within 6 months after given birth. Post-traumatic Stress Disorder (PTSD) Symptoms will be assessed by the Impact of Events Scale-6. This scale includes a total of six items: two items from each of the three subscales of the measure, namely intrusion, hyperarousal and avoidance. Participants will be asked to report their PTSD symptoms in the past 7 days on a Likert Scale ranging from 0 (not at all) to 4 (extremely).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Pregistry
🇺🇸Los Angeles, California, United States